Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 3, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific changes in share interests held by the GlaxoSmithKline Employee Trust ("GSK Trust") for the benefit of employees:
- October 6, 2006: The GSK Trust transferred 42,000 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991.
- November 2, 2006: The GSK Trust transferred 11,567 Ordinary Shares to participants in the same plan.
- November 2, 2006: The GSK Trust received 9,425 Ordinary Shares due to the reversal of an incorrect exercise.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions under Disclosure Rule 3.1.4R(1)(b).
Investor Verification Points
- Verify the total number of shares transferred to the SmithKline Beecham Employee Share Option Plan 1991 during the reporting period.
- Confirm the impact of the 9,425 share reversal on the GSK Trust's total holdings.
- Review the specific interests of Directors Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop in the GSK Trust.